{"id":2708,"date":"2023-05-03T15:39:03","date_gmt":"2023-05-03T13:39:03","guid":{"rendered":"https:\/\/www.jauch.com\/blog\/?p=2708"},"modified":"2025-04-15T08:33:26","modified_gmt":"2025-04-15T06:33:26","slug":"customer-success-story-reliable-power-supply-for-epilepsy-detection-during-sleep","status":"publish","type":"post","link":"https:\/\/www.jauch.com\/blog\/en\/customer-success-story-reliable-power-supply-for-epilepsy-detection-during-sleep\/","title":{"rendered":"Customer Success Story: Reliable Power Supply for Epilepsy Detection during Sleep"},"content":{"rendered":"\n

Approximately 1 percent of people worldwide suffer\nfrom epilepsy. In numbers, that’s one in 100 to one in 150 people. In 30\npercent of them, the disease is even incurable. This means that they are unable\nto control their seizures with the help of medication. Recurrent seizures are\nthe result. <\/p>\n\n\n\n

\u201cSeizures that occur during sleep are obviously the most dangerous because of the limited ability to monitor them,” explains Danny Reiffers, Product Specialist at LivAssured. According to the ILAE (International League Against Epilepsy), an average of 86 percent of nocturnal seizures go unnoticed. <\/p>\n\n\n\n

Reiffers goes on to say that people who experience\nfrequent nocturnal severe motor seizures are at higher risk for SUDEP. This\nstands for “Sudden Unexpected Death in Epilepsy\u201d, and happens to one in\n1000 people with epilepsy. In the case of drug resistance, that\u2019s as many as\none in 330. <\/p>\n\n\n\n

“It has also been shown that the likelihood of SUDEP decreases by 70 percent if the person with epilepsy is monitored in a room during sleep. This could be a parent sleeping next to their child, but it could also be a reliable epilepsy seizure detection device.”<\/p>\n\n\n

\n
\"\"
NightWatch enables parents and carers to sleep more soundly.<\/figcaption><\/figure><\/div>\n\n\n

And that’s where NightWatch<\/a>, LivAssured’s product, comes in: This is a reliable system that alerts remote responders in the event of a seizure. The product was developed through a unique cooperation of different institutions. For example, back in 2011, Utrecht University Hospital, SEIN and Kempenhaeghe\/ Eindhoven University of Technology joined forces to form the Tele-Epilepsy Consortium. Patient representatives from the Epilepsy Fund were also involved. Then, in 2013, LivAssured was formed to commercialize the technology that resulted from the collaboration. <\/p>\n\n\n\n

The product: an armband for early detection of seizures<\/strong><\/h2>\n\n\n
\n
\"\"
The arm module tracks all parameters to detect an epileptic seizure at an early stage.<\/figcaption><\/figure><\/div>\n\n\n

At the heart of the solution is a unique algorithm that can detect specific heart rate and motion patterns that indicate a clinically urgent seizure. For this purpose, a group of patients was followed and monitored over several years, so that a large amount of data was available. Because NightWatch tracks both heart rate and movement, the device can detect different types of seizures with a high degree of accuracy.<\/p>\n\n\n\n

“NightWatch is designed for patients, parents, caregivers and attendants who are looking for an effective way to receive timely warning of epileptic seizures during sleep,” Reiffers explains. “The product has been extensively clinically validated in multiple clinical trials in children and adults, demonstrating the performance of the system.”<\/p>\n\n\n\n

\n
\"YouTube\"

Mit dem Laden des Videos akzeptieren Sie die Datenschutzerkl\u00e4rung von YouTube.
Mehr erfahren<\/a><\/p>

Video laden<\/a><\/p>